 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
 M MUSCULO-SKELETAL SYSTEM
|
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
M03 MUSCLE RELAXANTS
|
M04 ANTIGOUT PREPARATIONS
|
M05 DRUGS FOR TREATMENT OF BONE DISEASES
|
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
|
M05BA Bisphosphonates [DG:DG01600]
|
M05BA01 Etidronic acid [DG:DG00780]
|
M05BA02 Clodronic acid [DG:DG00781]
|
M05BA03 Pamidronic acid [DG:DG00782]
|
M05BA04 Alendronic acid [DG:DG00783]
|
M05BA05 Tiludronic acid [DG:DG00784]
|
M05BA06 Ibandronic acid [DG:DG00785]
|
M05BA07 Risedronic acid [DG:DG00786]
|
 D08484 Risedronic acid (INN)
D00942 Risedronate sodium (USP) <US>
D03234 Sodium risedronate hydrate (JP18) <JP/US>
D11570 Risedronate sodium monohydrate <US>
|
M05BA08 Zoledronic acid [DG:DG00787]
|
M05BB Bisphosphonates, combinations
|
M05BC Bone morphogenetic proteins
|
M05BX Other drugs affecting bone structure and mineralization
|
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification